Skip to main content

Find Clinical Trials

Home
Conditions
Cholangiocarcinoma

Clinical trial condition

Cholangiocarcinoma

Explore clinical trials studying Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

503 public trials 160 recruiting studies

Refine in advanced search Browse all conditions

Cholangiocarcinoma trial results

Recruiting

Spanish Registry of Digestive Tumours RETUD

NCT06711211

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +30 more
Locations: Grupo de Tratamiento de los Tumores Digestivos (TTD) Madrid, Spain

View Trial Details

Recruiting

Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand

NCT05321992

Conditions: Adenocarcinoma, Adherence Interventions, Behavior, +17 more
Locations: Khon Kaen University Phu Wiang, Changwat Khon Kaen, Thailand

View Trial Details

Recruiting

Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma

NCT06341764

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
Locations: Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale Naples, Italia, Italy

Ospedale Cardarelli, Napoli Naples, Italia, Italy

Università di Napoli "Federico II", Napoli Naples, Italia, Italy

Ospedale san Camillo Forlanini/Spallanzani, Roma Roma, Italia, Italy

View Trial Details

Recruiting

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

NCT05223816

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Mayo Clinic Phoenix, Arizona, United States

Mayo Clinic Florida Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Recruiting

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

NCT06505486

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, China

View Trial Details

Recruiting

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors

NCT06487663

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, China

View Trial Details

Recruiting

Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma

NCT06298968

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma

NCT04340986

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Serviec hépatologie-Hôpital Saint Antoine Paris, France

View Trial Details

Recruiting

Perioperative Treatment of Resectable Intrahepatic Cholangiocarcinoma With the Combination of Adebrelimab and Apatinib and HAIC

NCT06296563

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Shandong Cancer Hospital and Institute Jinan, Shandong, China

View Trial Details

Recruiting

Registry for Advanced Endoscopy

NCT05187312

Conditions: Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +16 more
Locations: Karolinska University Hospital Stockholm, Sweden

View Trial Details